Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parasitic Diseases

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    July 2021
  1. FAN H, Gai W, Zhang L, Ma Y, et al
    Parasite Circulating Cell-free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator.
    Clin Infect Dis. 2021;73:e246-e251.
    PubMed     Abstract available


    May 2021
  2. KAMRAN M, Ejazi SA, Choudhury ST, Bhattacharyya A, et al
    A novel antigen, otubain cysteine peptidase of Leishmania donovani improves serodiagnosis of visceral leishmaniasis and monitors treatment response.
    Clin Infect Dis. 2021 May 13. pii: 6275590. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  3. AYABINA D, Kura K, Toor J, Graham M, et al
    Maintaining low prevalence of Schistosoma mansoni: modelling the effect of less frequent treatment.
    Clin Infect Dis. 2021 Apr 28. pii: 6256990. doi: 10.1093.
    PubMed     Abstract available


  4. COFFENG LE, Le Rutte EA, Munoz J, Adams E, et al
    Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study.
    Clin Infect Dis. 2021 Apr 27. pii: 6255961. doi: 10.1093.
    PubMed     Abstract available


  5. COFFENG LE, Levecke B, Hattendorf J, Walker M, et al
    Survey design to monitor drug efficacy for the control of soil-transmitted helminthiasis and schistosomiasis.
    Clin Infect Dis. 2021 Apr 27. pii: 6255959. doi: 10.1093.
    PubMed     Abstract available


  6. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  7. LAGO T, Carvalho L, Nascimento M, Guimaraes LH, et al
    Influence of Obesity on Clinical Manifestations and Response to Therapy in Cutaneous Leishmaniasis caused by Leishmania braziliensis.
    Clin Infect Dis. 2021 Mar 16. pii: 6174316. doi: 10.1093.
    PubMed     Abstract available


  8. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions.
    Clin Infect Dis. 2021 Mar 2. pii: 6157008. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  9. VERREST L, Kip AE, Musa A, Schoone GJ, et al
    Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa.
    Clin Infect Dis. 2021 Feb 13. pii: 6134305. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  10. MISCHLINGER J, Dudek V, Ramharter M
    Predictive performance of rapid diagnostic tests for falciparum malaria and its modelled impact on integrated community case management of malaria in sub-Saharan African febrile children.
    Clin Infect Dis. 2021 Jan 28. pii: 6121687. doi: 10.1093/cid/ciaa1942.
    PubMed     Abstract available


    November 2020
  11. MITCHELL CL, Topazian HM, Brazeau NF, Deutsch-Feldman M, et al
    Household prevalence of P. falciparum, P. vivax, and P. ovale in the Democratic Republic of the Congo, 2013-2014.
    Clin Infect Dis. 2020 Nov 26. pii: 6006303. doi: 10.1093/cid/ciaa1772.
    PubMed     Abstract available


    October 2020
  12. SOTO JA, Berman JD
    Miltefosine treatment of Cutaneous Leishmaniasis.
    Clin Infect Dis. 2020 Oct 31. pii: 5944710. doi: 10.1093/cid/ciaa1461.
    PubMed    


  13. WARE JM, O'Connell EM, Brown T, Wetzler L, et al
    Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
    Clin Infect Dis. 2020 Oct 28. pii: 5943554. doi: 10.1093/cid/ciaa1238.
    PubMed     Abstract available


    September 2020
  14. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed     Abstract available


  15. HOUNKONNOU CPA, Ndam NT, Fievet N, Accrombessi M, et al
    Sub-optimal Intermittent Preventive Treatment in pregnancy (IPTp) is associated with an increased risk of submicroscopic P. falciparum infection in pregnant women: a prospective cohort study in Benin.
    Clin Infect Dis. 2020 Sep 9. pii: 5903262. doi: 10.1093/cid/ciaa1355.
    PubMed     Abstract available


  16. MACHADO PRL, Prates FVO, Boaventura V, Lago T, et al
    A double-bind and randomized trial to evaluate Miltefosine and topical GM-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil.
    Clin Infect Dis. 2020 Sep 7. pii: 5902344. doi: 10.1093/cid/ciaa1337.
    PubMed     Abstract available


    August 2020
  17. CASTELLUCCI LC, Almeida L, Cherlin S, Fakiola M, et al
    A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.
    Clin Infect Dis. 2020 Aug 23. pii: 5896307. doi: 10.1093/cid/ciaa1230.
    PubMed     Abstract available


  18. POTVIN JE, Leprohon P, Queffeulou M, Sundar S, et al
    Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani.
    Clin Infect Dis. 2020 Aug 22. pii: 5895967. doi: 10.1093/cid/ciaa1236.
    PubMed     Abstract available


  19. GOMEZ MA, Navas A, Prieto M, Giraldo-Parra L, et al
    Immuno-pharmacokinetics of meglumine antimoniate in patients with cutaneous leishmaniasis caused by Leishmania Viannia.
    Clin Infect Dis. 2020 Aug 20. pii: 5895071. doi: 10.1093/cid/ciaa1206.
    PubMed     Abstract available


  20. UYOGA S, Wanjiku P, Rop JC, Makale J, et al
    Plasma Plasmodium falciparum Histidine-Rich Protein-2 concentrations in children with malaria infections of differing severity in Kilifi, Kenya.
    Clin Infect Dis. 2020 Aug 9. pii: 5890098. doi: 10.1093/cid/ciaa1141.
    PubMed     Abstract available


    July 2020
  21. KUBLIN JG, Murphy SC, Maenza J, Seilie AM, et al
    Safety, pharmacokinetics and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study.
    Clin Infect Dis. 2020 Jul 9. pii: 5869402. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  22. JAFARI-GUEMOURI S, Courtois L, Mama A, Rouas B, et al
    A genotypical study in Benin comparing the carriage of P. falciparum infections before pregnancy and in the early pregnancy: story of a persistent infection.
    Clin Infect Dis. 2020 Jun 22. pii: 5860917. doi: 10.1093.
    PubMed     Abstract available


  23. BUNDI CK, Nalwoga A, Lubyayi L, Muriuki JM, et al
    Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children.
    Clin Infect Dis. 2020 Jun 7. pii: 5854375. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  24. MAIRET-KHEDIM M, Leang R, Marmai C, Khim N, et al
    Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia.
    Clin Infect Dis. 2020 May 27. pii: 5847731. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  25. CNOPS L, Huyse T, Maniewski U, Soentjens P, et al
    Acute Schistosomiasis with A S. Mattheei x S. Haematobium Hybrid Species in a Cluster of 34 Travelers Infected in South Africa.
    Clin Infect Dis. 2020 Mar 26. pii: 5812135. doi: 10.1093.
    PubMed     Abstract available


  26. STOTHARD R, Webster BL
    Acute schistosomiasis: Which molecular diagnostic test is best and why.
    Clin Infect Dis. 2020 Mar 26. pii: 5812133. doi: 10.1093.
    PubMed    


    February 2020
  27. PHU NH, Day NPJ, Tuan PQ, Mai NTH, et al
    Concomitant bacteremia in adults with severe falciparum malaria.
    Clin Infect Dis. 2020 Feb 28. pii: 5763096. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  28. PETERSEN E, Gradoni L, McLellan S
    Human Genetics Influence the Susceptibility to Cutaneous Leishmanisis Caused by Leishmania guyanensis.
    Clin Infect Dis. 2019 Nov 13. pii: 5624996. doi: 10.1093.
    PubMed    


  29. DA SILVA GAV, Mesquita TG, Souza VC, Junior JDES, et al
    A Single Haplotype of IFNG Correlating With Low Circulating Levels of Interferon-gamma Is Associated With Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis.
    Clin Infect Dis. 2019 Nov 13. pii: 5625012. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  30. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
    Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
    Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
    PubMed     Abstract available


    September 2019
  31. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Abstract available


  32. HOUNKONNOU CPA, Briand V, Fievet N, Accrombessi M, et al
    Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.
    Clin Infect Dis. 2019 Sep 12. pii: 5563807. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  33. LIN JT, Parr JB, Ngasala B
    Non-falciparum malaria in Africa and learning from P. vivax in Asia.
    Clin Infect Dis. 2019 Aug 13. pii: 5549499. doi: 10.1093.
    PubMed    


  34. ACHAN J, Reuling I, Yap XZ, Dabira E, et al
    Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum controlled human infection.
    Clin Infect Dis. 2019 Aug 12. pii: 5546068. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  35. BUI QUANG P, Huynh Hong Q, Tran Thanh D, Le Thanh D, et al
    Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017-2018).
    Clin Infect Dis. 2019 Jun 28. pii: 5525051. doi: 10.1093.
    PubMed     Abstract available


  36. OKOMBO J, Fidock DA
    Pyronaridine-Artesunate Shows Promise as an Effective and Well-Tolerated Treatment for Artemisinin-Resistant Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Jun 28. pii: 5524934. doi: 10.1093.
    PubMed    


    May 2019
  37. CRAINEY JL, Bessa Luz SL
    Light Microscopic Detection of Mansonella ozzardi Parasitemias.
    Clin Infect Dis. 2019;68:2156.
    PubMed    


    March 2019
  38. ELKET N, Kendjo E, Thellier M, Assoumou L, et al
    Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France.
    Clin Infect Dis. 2019 Mar 15. pii: 5381062. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  39. AWANDU SS, Raman J, Bousema T, Birkholtz LM, et al
    Ultra-low-density Plasmodium falciparum infections in African settings.
    Clin Infect Dis. 2019 Feb 15. pii: 5320191. doi: 10.1093.
    PubMed    


  40. YEO TW, Weinberg JB, Lampah DA, Kenangalem E, et al
    Glycocalyx Breakdown is Associated with Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Feb 12. pii: 5316441. doi: 10.1093.
    PubMed     Abstract available


  41. BRADLEY J, Soumare HM, Mahamar A, Diawara H, et al
    Transmission-blocking effects of primaquine and methylene blue suggest P. falciparum gametocyte sterilisation rather than effects on sex ratio.
    Clin Infect Dis. 2019 Feb 12. pii: 5316265. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  42. ISLAM S
    AmBisome for Kala-azar and Post-Kala-Azar Dermal Leishmaniasis: An essential option but not a universal solution.
    Clin Infect Dis. 2018 Dec 18. pii: 5250912. doi: 10.1093/cid/ciy1033.
    PubMed    


  43. MOLLETT G, Bremer Hinckel BC, Bhattacharyya T, Marlais T, et al
    Detection of IgG1 against rK39 improves monitoring of treatment outcome in visceral leishmaniasis.
    Clin Infect Dis. 2018 Dec 12. pii: 5239677. doi: 10.1093/cid/ciy1062.
    PubMed     Abstract available


    November 2018
  44. MCCARTHY JS, Smith B, Reid M, Berman J, et al
    Blood schizonticidal activity and safety of tafenoquine when administered as chemoprophylaxis to healthy, non-immune participants followed by blood stage Plasmodium falciparum challenge: A randomized, double-blinded, placebo-controlled Phase 1b study.
    Clin Infect Dis. 2018 Nov 1. pii: 5154907. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  45. MONDAL D, Bern C, Ghosh D, Rashid M, et al
    Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies.
    Clin Infect Dis. 2018 Oct 24. pii: 5144025. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  46. SOTO J, Soto P, Ajata A, Luque C, et al
    Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Clin Infect Dis. 2018 Sep 27. pii: 5107841. doi: 10.1093.
    PubMed     Abstract available


  47. MODY RM, Lakhal-Naouar I, Sherwood JE, Koles NL, et al
    Asymptomatic Visceral Leishmania infantum Infection in U.S. Soldiers Deployed to Iraq.
    Clin Infect Dis. 2018 Sep 20. pii: 5103944. doi: 10.1093.
    PubMed     Abstract available


  48. MBUI J, Olobo J, Omollo R, Solomos A, et al
    Pharmacokinetics, safety and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase-II clinical trial.
    Clin Infect Dis. 2018 Sep 5. pii: 5090844. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  49. LE RUTTE EA, Chapman LAC, Coffeng LE, Ruiz-Postigo JA, et al
    Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent.
    Clin Infect Dis. 2018;66.
    PubMed     Abstract available


  50. TOOR J, Alsallaq R, Truscott JE, Turner HC, et al
    Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
    Clin Infect Dis. 2018;66.
    PubMed     Abstract available


    May 2018
  51. BUCHWALD AG, Sixpence A, Chimenya M, Damson M, et al
    Clinical implications of asymptomatic Plasmodium falciparum infections in Malawi.
    Clin Infect Dis. 2018 May 16. pii: 4996917. doi: 10.1093.
    PubMed     Abstract available


  52. TUIKUE NDAM N, Tornyigah B, Dossou AY, Escriou G, et al
    Persistent Plasmodium falciparum infection in women with an intent to become pregnant is a risk factor for pregnancy-associated malaria.
    Clin Infect Dis. 2018 May 4. pii: 4992589. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  53. DEN BOER M, Das AK, Akhter F, Burza S, et al
    Safety and effectiveness of short-course AmBisome in the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a prospective cohort study in Bangladesh.
    Clin Infect Dis. 2018 Mar 15. pii: 4938630. doi: 10.1093.
    PubMed     Abstract available


  54. GALATAS B, Marti-Soler H, Nhamussua L, Cistero P, et al
    Dynamics of afebrile Plasmodium falciparum Infections in Mozambican Men.
    Clin Infect Dis. 2018 Mar 13. pii: 4931589. doi: 10.1093.
    PubMed     Abstract available


  55. PLEWES K, Kingston HWF, Ghose A, Wattanakul T, et al
    Acetaminophen as a Renoprotective Adjunctive Treatment in Patients with Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.
    Clin Infect Dis. 2018 Mar 12. pii: 4930781. doi: 10.1093.
    PubMed     Abstract available


  56. TRIPURA R, Peto TJ, Nguon C, Davoeung C, et al
    A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multi Drug Resistant Falciparum Malaria in Cambodian Villages.
    Clin Infect Dis. 2018 Mar 7. pii: 4924016. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  57. VALMASEDA A, Macete E, Nhabomba A, Guinovart C, et al
    Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure.
    Clin Infect Dis. 2018;66:586-593.
    PubMed     Abstract available


    January 2018
  58. ROSSI G, Vernaeve L, Van den Bergh R, Nguon C, et al
    Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia.
    Clin Infect Dis. 2018 Jan 18. pii: 4816713. doi: 10.1093/cid/cix1064.
    PubMed     Abstract available


  59. TADESSE FG, Slater HC, Chali W, Teelen K, et al
    The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia.
    Clin Infect Dis. 2018 Jan 3. pii: 4786592. doi: 10.1093/cid/cix1123.
    PubMed     Abstract available


    December 2017
  60. MOMBO-NGOMA G, Remppis J, Sievers M, Zoleko Manego R, et al
    Efficacy and safety of fosmidomycin-piperaquine as non-artemisinin-based combination therapy for uncomplicated falciparum malaria - A single-arm, age-de-escalation proof of concept study in Gabon.
    Clin Infect Dis. 2017 Dec 26. pii: 4774674. doi: 10.1093/cid/cix1122.
    PubMed     Abstract available


    September 2017
  61. MOULIK S, Chaudhuri SJ, Sardar B, Ghosh M, et al
    Monitoring of parasite kinetics in Indian Post Kala Azar Dermal Leishmaniasis.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    PubMed     Abstract available


  62. DIRO E, Ritmeijer K, Boelaert M, Alves F, et al
    Long-term clinical outcomes in visceral leishmaniasis-HIV co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial Authors and affiliations.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    PubMed     Abstract available


  63. ROSSI G, Van den Bergh R, Nguon C, Debackere M, et al
    Adapting reactive case detection strategies for falciparum malaria in a low-transmission area in Cambodia.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Abstract available


    August 2017
  64. TOURE OA, Mwapasa V, Sagara I, Gaye O, et al
    Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, R
    Clin Infect Dis. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available


  65. BOYCE R, Reyes R, Matte M, Ntaro M, et al
    Use of a Dual-Antigen Rapid Diagnostic Test to Screen Children for Severe Plasmodium falciparum Malaria in a High-Transmission, Resource-Limited Setting.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Abstract available


    July 2017
  66. ABONGOMERA C, Diro E, Vogt F, Tsoumanis A, et al
    The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Abstract available


    June 2017
  67. TINE RC, Sylla K, Faye BT, Poirot E, et al
    Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    PubMed     Abstract available


    May 2017
  68. MOLINA R, Ghosh D, Carrillo E, Monnerat S, et al
    Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
    Clin Infect Dis. 2017 May 18. doi: 10.1093.
    PubMed     Abstract available


  69. WYSS K, Wangdahl A, Vesterlund M, Hammar U, et al
    Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results from a Swedish Nationwide Study.
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Abstract available


  70. BJORKMAN A, Cook J, Sturrock H, Msellem M, et al
    Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers.
    Clin Infect Dis. 2017;64:1236-1243.
    PubMed     Abstract available


    April 2017
  71. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Abstract available


  72. CHERNET A, Kling K, Sydow V, Kuenzli E, et al
    Accuracy of diagnostic tests for Schistosoma mansoni infection in asymptomatic Eritrean refugees: serology and POC-CCA against stool microscopy.
    Clin Infect Dis. 2017 Apr 19. doi: 10.1093.
    PubMed     Abstract available


  73. IPPOLITO MM, Johnson J, Mullin C, Mallow C, et al
    The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017 Apr 11. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  74. NEUMAYR A, Paris D, Genton B, Hatz C, et al
    Artemether-lumefantrine treatment failure in nonimmune European travelers with P. falciparum malaria: 5.3% now and 5.3% then - need to reconsider dosing in patients from non-endemic regions?
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed    


  75. PORTUGAL S, Tran TM, Ongoiba A, Bathily A, et al
    Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection.
    Clin Infect Dis. 2017;64:645-653.
    PubMed     Abstract available


    February 2017
  76. WHITE NJ
    The Consequences of Treating Asymptomatic Malaria Parasitemia.
    Clin Infect Dis. 2017 Feb 8. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: